The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Consulting or Advisory Role - LIM Innovations
A pilot study of a comprehensive financial navigation program in cancer patients and caregivers.
 
Jordan Steelquist
Research Funding - AstraZeneca
 
Kate Watabayashi
No Relationships to Disclose
 
Karen Overstreet
No Relationships to Disclose
 
Tony Leahy
No Relationships to Disclose
 
Alan James Balch
No Relationships to Disclose
 
Erin Bradshaw
No Relationships to Disclose
 
Kathleen D. Gallagher
Consulting or Advisory Role - LIM Innovations
 
Rebecca Lobb
No Relationships to Disclose
 
Laura Lavell
No Relationships to Disclose
 
Hannah M. Linden
Leadership - Evolent (I)
Stock and Other Ownership Interests - Evolent (I)
Consulting or Advisory Role - AstraZeneca; Context Therapeutics; Genomic Health; Syndax
Research Funding - Eisai; GTx (Inst); Sanofi/Aventis (Inst)
 
Scott David Ramsey
Consulting or Advisory Role - AstraZeneca; Bayer; Bristol-Myers Squibb; Cascadian Therapeutics; Epigenomics; Genentech; Kite, a Gilead company; Merck; Seagen
Research Funding - Bayer (Inst); Bristol-Myers Squibb (Inst); Microsoft (Inst)
Travel, Accommodations, Expenses - Bayer Schering Pharma; Bristol-Myers Squibb; Flatiron Health
 
Veena Shankaran
Honoraria - Proteus Digital Health; Taiho Pharmaceutical
Research Funding - Amgen (Inst); AstraZeneca (Inst); Bayer (Inst); Bristol-Myers Squibb (Inst); Merck (Inst)
Travel, Accommodations, Expenses - Proteus Digital Health; Taiho Pharmaceutical